The “Clinical Development in LATAM: Brazil Unlocked” event will take place on Thursday, September 24, 2026, starting at 3:30 PM EDT, at the MassBio Hub – Kendall Square in Cambridge, Massachusetts.

The event will focus on the evolving landscape of clinical research and drug development in Brazil and across Latin America, including opportunities and practical considerations for sponsors, CROs, biotech companies, and other life-sciences organizations seeking to conduct clinical studies in the region. Discussions will explore Brazil’s growing role in global clinical development, its diverse patient population, research infrastructure, and the factors shaping successful clinical trial execution in Latin America.